TI - Cost-Effectiveness of Pembrolizumab in Combination with Platinum-Based Chemotherapy in First-Line for Squamous and Nonsquamous Non Small-Cell Lung Cancer. Far from Economic Sustainability
PT - Journal Article
DP - 2021
TA - EJMO
PG - 59-62
VI - 5
IP - 1
AID - 2021.96518 [doi]
4100 - https://dx.doi.org/10.14744/ejmo.2021.96518
SO - EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY,2021 5(1): 59